It could be a good idea to buy these ASX blue chip shares if there's a market correction in 2026. Let's find out ...

Morgans sees major upside potential in this ASX 200 stock. The broker has a buy rating and $32.30 price target on the Mexican ...

Morgans healthcare analysts give Stockhead readers their top picks for 2026 after a tough year for the sector.

Is there any upside for insurance shares after a down year? The post Which ASX insurance stocks performed best this year?

As the Australian market approaches the holiday season, it seems to be winding down with a slight dip, likely due to profit-taking before the break. In such a market landscape, investors often seek ...

The S & P/ASX 200 was down 0.2 per cent or 17.6 points to 8745.1 near 11.30 am (AEDT), having rallied 1.6 per cent last week.

Let's see which shares short sellers are targeting this week. The post These are the 10 most shorted ASX shares appeared ...

No one's crossed the finishing line yet, but drug developer Nyrada is leading the Great Biotech Regatta of 2025 with close to ...

Key Insights Institutions' substantial holdings in Lynas Rare Earths implies that they have significant influence ...

Investing.com-- Shares in ASX Ltd (ASX:ASX) slipped on Monday after the country’s corporate watchdog imposed a A$150 million ($99.7 million) capital charge on the exchange operator following an ...

Australia's bourse operator ASX said on Monday that it will cut its dividend payout ratio to 75–85% of underlying net profit ...

While the Federal Reserve cut interest rates in the US a couple of days back, in Australia, the trend appears to be moving in ...